Suppr超能文献

凝集素样氧化型低密度脂蛋白受体1(LOX-1)在动脉粥样硬化发生中的作用:简要综述

Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.

作者信息

Reiss Allison B, Anwar Kamran, Wirkowski Peter

机构信息

Vascular Biology Institute, Department of Medicine, Winthrop-University Hospital, Suite 502, Mineola, NY 11501, USA.

出版信息

Curr Med Chem. 2009;16(21):2641-52. doi: 10.2174/092986709788681994.

Abstract

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a scavenger receptor that primarily binds and regulates oxidized low-density lipoprotein (LDL). Expression of LOX-1 is regulated by a feed-forward system stimulated by oxidized LDL (oxLDL), a major component of atherosclerosis. LOX-1 is a homodimer with a reactive backbone that can bind to a host of different ligands, including small molecules, and whole cells. LOX-1 is involved in many intercellular, intracellular, and molecular processes that are atherogenic. LOX-1 levels are elevated within atherosclerotic plaques and its expression is induced by proinflammatory cytokines. The ability of LOX-1 to bind many different ligands and control several atherogenic processes makes this receptor a likely vascular disease biomarker as well as an ideal choice for drug therapy aimed at preventing cardiovascular disease.

摘要

凝集素样氧化型低密度脂蛋白受体-1(LOX-1)是一种清道夫受体,主要结合并调节氧化型低密度脂蛋白(LDL)。LOX-1的表达受氧化型LDL(oxLDL)刺激的前馈系统调节,氧化型LDL是动脉粥样硬化的主要成分。LOX-1是一种同型二聚体,具有反应性骨架,可与许多不同的配体结合,包括小分子和完整细胞。LOX-1参与许多促动脉粥样硬化的细胞间、细胞内和分子过程。LOX-1水平在动脉粥样硬化斑块内升高,其表达由促炎细胞因子诱导。LOX-1结合多种不同配体并控制多个促动脉粥样硬化过程的能力,使该受体成为可能的血管疾病生物标志物,也是旨在预防心血管疾病的药物治疗的理想选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验